| AstraZeneca AG - Calquence 100 mg, Filmtabletten | | 68817 | | 01 | | Calquence 100 mg | | Filmtabletten | | L01EL02 | | | | 04.05.2023 | | |
| | Composition | | acalabrutinibum 100 mg ut acalabrutinibi maleas monohydricus, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, natrii stearylis fumaras, Überzug: hypromellosum, copovidonum, E 171, macrogolum 3350, triglycerida media, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium 0.59 mg. | | Packungsbestandteile | | Coated tablets | | | | | | BAG: Active Agent | Dose |
|---|
| | 100 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | | | | | | color. | | | | color. | | | | | | Hypromellosum | | Überzug | | Macrogol | 3350 | | | Mannitol | | | | | | | | | | | | | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 60 | 4426.76 | 4830.80 | A | SL | No |
|
|
